Please login to the form below

Not currently logged in
Email:
Password:

Boehringer & Ashoka focus on communities

Boehringer Ingelheim and Ashoka will launch a three-year global initiative to improve health in communities around the world

Boehringer Ingelheim and Ashoka will launch a three-year global initiative to improve health in communities around the world.

The "Making More Health" project will promote healthy individuals, families and communities by identifying and supporting the most promising solutions to challenging health problems. 

The partnership includes support for a series of programmes aimed at identifying innovative health solutions, including the election of 50 leading social entrepreneurs whose ideas are driving cutting-edge systemic solutions in the field of health. In addition, two web-based competitions will open an invitation to the public to submit new ideas on how to improve health in underserved communities. 

The initiative will also focus on the next generation through a youth venture programme to engage young people in designing health solutions for their communities.

Boehringer Ingelheim will support the initiative by engaging its 42,000 employees worldwide in various capacities to help spread an understanding and appreciation of entrepreneurship and health innovation within their own communities.

Professor Dr Andreas Barner, chairman of the board of managing directors at Boehringer Ingelheim, said: "Making More Health brings together two organisations committed to finding innovative people and ideas to help shape the future of the health sector.

"Through this partnership we will bring forth meaningful and sustainable solutions that can achieve individual and family well-being in communities around the globe," he added.

23rd June 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...